Target intelligence / Profile preview

Immunoglobulin kappa variable 2-26 (IGKV2-26)

Target
IGKV2-26
Molecular classification
Immunoglobulin variable region gene (pseudogene), Other (does not encode a receptor, enzyme, or transporter)
01

Overview

Immunoglobulin kappa variable 2-26 (IGKV2-26) is a member of the immunoglobulin kappa light chain variable gene family located in the immunoglobulin kappa locus on chromosome 2. It is annotated as an IG V pseudogene, meaning it does not produce a functional immunoglobulin kappa light chain variable region protein. Pseudogenes like IGKV2-26 are characterized by mutations or deletions that prevent them from encoding functional protein products. While functional immunoglobulin variable regions are essential for antigen diversity in antibodies, IGKV2-26 does not contribute to the antigen-binding repertoire and has no known direct role in immunity, disease, or therapeutic targeting. IGKV2-26 is part of the highly polymorphic immunoglobulin kappa locus, which contains functional, ORF, and pseudogene segments. The nomenclature may cause confusion, as IGKV2-26 (proximal cluster) and IGKV2D-26 (distal cluster) are both pseudogenes and are not functional antigen receptor genes. No evidence supports this molecule as a receptor, enzyme, or drug target. No therapeutic drugs or biomarkers exist for IGKV2-26.

Other names
IGKV226IGKV2-26A21IGKV2D-26
02

Mechanism of action

None

03

Biological functions

None (does not produce functional protein; pseudogene)
04

Disease associations

None (no direct disease role associated, functions as germline genetic variation in immunoglobulin loci)
05

Safety considerations

None (not a functional molecule in pharmacological context)
06

Interacting drugs

None (no drugs target this pseudogene)
07

Biomarkers

None (not used as biomarker for patient selection or efficacy monitoring)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2-26 (IGKV2-26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2-26 (IGKV2-26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call